Balyasny Asset Management LLC Jazz Pharmaceuticals PLC Transaction History

Balyasny Asset Management LLC

$54.8 Billion
Q1 2024

A detailed history of Balyasny Asset Management LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Balyasny Asset Management LLC holds 5,293 shares of JAZZ stock, worth $564,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,293

Previous 50,000 89.41%

Holding current value

$564,921

Previous $6.15 Million 89.64%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$115.19 - $132.77 $22.5 Million - $25.9 Million	-195,160 Reduced 97.36%	5,293 $637,000
Q4 2023 Feb 14, 2024	BUY	$114.26 - $136.0 $14.8 Million - $17.6 Million	129,531 Added 182.64%	200,453 $24.7 Million
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $5.12 Million - $6.1 Million	-42,007 Reduced 37.2%	70,922 $9.18 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $13.8 Million - $16.6 Million	112,929 New	112,929 $14 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $21.2 Million - $26.1 Million	163,382 New	163,382 $26 Million

Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $721,825 - $859,828	-5,098 Reduced 5.99%	79,986 $12.5 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $11 Million - $13.7 Million	85,084 New	85,084 $13.2 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $24.3 Million - $34.8 Million	-188,541 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $4.45 Million - $5.17 Million	-27,750 Reduced 12.83%	188,541 $33.5 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $30.4 Million - $35.7 Million	216,291 New	216,291 $35.7 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $22.4 Million - $29.3 Million	-190,414 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$125.18 - $143.24 $21.5 Million - $24.6 Million	171,678 Added 916.3%	190,414 $24.4 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $801,385 - $922,215	6,383 Added 51.67%	18,736 $2.67 Million
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $1.5 Million - $1.77 Million	12,353 New	12,353 $1.77 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $6.77 Million - $9.73 Million	-58,365 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $6.51 Million - $7.3 Million	-40,451 Reduced 40.94%	58,365 $9.81 Million
Q2 2018 Aug 14, 2018	SELL	$146.33 - $183.18 $7.94 Million - $9.95 Million	-54,291 Reduced 35.46%	98,816 $17 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $15.2 Million - $17.7 Million	-112,387 Reduced 42.33%	153,107 $23.1 Million
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $34.8 Million - $39.9 Million	265,494	265,494 $35.7 Million

Others Institutions Holding JAZZ

# of Institutions

514

Shares Held

57.1M

Call Options Held

65.9K

Put Options Held

183K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.69B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account

Balyasny Asset Management LLC Jazz Pharmaceuticals PLC Transaction History